Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academics Conferences
Pierre A. MORGON is Chief Executive Officer of MRGN Advisors, a consultancy dedicated to the healthcare sector, and Regional Partner for Switzerland at Mérieux Développement, an evergreen investment structure focused on medical devices, in vitro diagnostics and patient management services. Chairman of the Board of Virometix, a company developing proprietary synthetic nanoparticle platform in vaccines and immunotherapeutic drugs for viral diseases and cancer. He holds a Doctorate of Pharmacy, a Master in Business Law and a MBA. He is also an alumnus of INSEAD, IMD and MCE executive programs. Board positions: Non-Executive Director to the Board of Theradiag, a company focusing on in vitro diagnostics in auto-immunity, infectious diseases and allergy. Non-Executive Director to the Board of Eurocine Vaccines, a company dedicated to developing intra nasal vaccines.